NCT01945242View on ClinicalTrials.gov

"Alogliptin Tablets Special Drug Use Surveillance Type 2 Diabetes Mellitus: Combination Therapy With Thiazolidinediones"

CompletedOBSERVATIONAL
Enrollment

1,374

Participants

Timeline

Start Date

March 31, 2011

Primary Completion Date

June 30, 2014

Study Completion Date

June 30, 2014

Conditions
Type 2 Diabetes Melitus
Interventions
DRUG

Alogliptin

Alogliptin tablets

Sponsors

Lead Sponsor

Takeda
All Listed Sponsors
lead

Takeda

INDUSTRY